Photodynamic Therapy and Metal-Based Photosensitisers
Author Information
Author(s): Leanne B. Josefsen, Ross W. Boyle
Primary Institution: The University of Hull
Hypothesis
Can the development of new metal-based photosensitisers improve the efficacy of photodynamic therapy?
Conclusion
The review highlights the advancements in metal-based photosensitisers that have been developed to enhance the effectiveness of photodynamic therapy.
Supporting Evidence
- Photodynamic therapy has been used successfully for various diseases including cancers and age-related macular degeneration.
- Newer photosensitisers aim to reduce the side effects associated with first-generation agents like Photofrin.
- Metal-based photosensitisers have shown promise in improving the selectivity and efficacy of photodynamic therapy.
Takeaway
Photodynamic therapy uses special drugs that become active when exposed to light to kill diseased cells, and new metal-based drugs are being developed to make this treatment better.
Methodology
The review discusses various metal-based photosensitisers and their mechanisms in photodynamic therapy, including their absorption properties and clinical applications.
Limitations
The review does not provide specific experimental data or clinical trial results for the discussed photosensitisers.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website